Investigations reveal how SETD6 modifies E2F1, influencing gene regulation and cancer traits in prostate cancer cells, suggesting a broader regulatory mechanism.
Key Points
This research aims to explore the role of SETD6-mediated K117 methylation of E2F1 in prostate cancer cells.
Conducted chromatin binding and gene expression experiments in prostate cancer cells
Utilized biochemical and genomic assays to analyze E2F1 interactions
Investigated the effects of E2F1 methylation on oncogenic phenotypes
Identified distinct gene sets bound and upregulated by methylated and unmethylated E2F1
Demonstrated that K117 methylation prevents K117 acetylation, affecting E2F1 and BRD4 interaction
Suggested that K117 methylation acts as a switch regulating E2F1's cellular effects